Adial Pharmaceuticals, Inc. Diluted Shares Outstanding (Weighted Average)
Adial Pharmaceuticals, Inc. (ADIL) reported Diluted Shares Outstanding (Weighted Average) of 4.62 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-14
- Adial Pharmaceuticals, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 4.62M shares, a 987.70% increase year-over-year.
- Adial Pharmaceuticals, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 1.37M shares, a 423.76% increase year-over-year.
- Adial Pharmaceuticals, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was -36.84M shares.
- Adial Pharmaceuticals, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 22.17M shares, a 279.93% increase year-over-year.
- Adial Pharmaceuticals, Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 668.63K shares, a 244.55% increase from fiscal 2024.
- Adial Pharmaceuticals, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 194.06K shares, a 86.38% decline from fiscal 2023.
- Adial Pharmaceuticals, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 1.42M shares, a 42.25% increase from fiscal 2022.
- Adial Pharmaceuticals, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 1.00M shares, a 94.61% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 4.62M shares 10-Q · filed 2026-08-14 | 3.00M shares 10-Q · filed 2026-08-14 | -10.28M shares derived: average of 3 quarters · filed 2026-08-14 | -2.17M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | 1.37M shares 10-Q · filed 2026-05-08 | -17.73M shares derived: average of 2 quarters · filed 2026-05-08 | -4.43M shares derived: average of 3 quarters · filed 2026-05-08 | -3.22M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | -36.84M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -7.33M shares derived: average of 2 quarters · filed 2026-03-05 | -4.75M shares derived: average of 3 quarters · filed 2026-08-14 | 668.63K shares 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | 22.17M shares 10-Q · filed 2025-11-13 | 11.30M shares derived: average of 2 quarters · filed 2026-08-14 | 13.17M shares 10-Q · filed 2025-11-13 | 2.66M shares derived: average of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | 424.91K shares 10-Q · filed 2026-08-14 | 10.62M shares 10-Q · filed 2025-08-13 | 343.70K shares 10-Q · filed 2026-08-14 | 8.59M shares 10-Q · filed 2025-08-13 | -3.84M shares derived: average of 3 quarters · filed 2026-08-14 | -1.42M shares derived: average of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | 261.59K shares 10-Q · filed 2026-05-08 | 6.54M shares 10-Q · filed 2025-05-14 | -5.98M shares derived: average of 2 quarters · filed 2026-05-08 | -2.04M shares derived: average of 3 quarters · filed 2026-05-08 | -483.55K shares derived: average of 4 quarters · filed 2026-05-08 | |||
| 2024-12-31 | -12.21M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -3.19M shares derived: average of 2 quarters · filed 2026-03-05 | -731.93K shares derived: average of 3 quarters · filed 2026-03-05 | 194.06K shares 10-K · filed 2026-03-05 | 4.85M shares 10-K · filed 2025-03-04 | |||
| 2024-09-30 | 5.84M shares 10-Q · filed 2025-11-13 | 5.01M shares derived: average of 2 quarters · filed 2025-11-13 | 4.33M shares 10-Q · filed 2025-11-13 | 3.83M shares derived: average of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | 4.18M shares 10-Q · filed 2025-08-13 | 3.57M shares 10-Q · filed 2025-08-13 | 3.16M shares derived: average of 3 quarters · filed 2025-08-13 | 2.66M shares derived: average of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | 2.95M shares 10-Q · filed 2025-05-14 | 2.64M shares derived: average of 2 quarters · filed 2025-05-14 | 2.16M shares derived: average of 3 quarters · filed 2025-05-14 | 1.90M shares derived: average of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | 2.33M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | 1.76M shares derived: average of 2 quarters · filed 2025-03-04 | 1.55M shares derived: average of 3 quarters · filed 2025-03-04 | 1.42M shares 10-K · filed 2025-03-04 | ||||
| 2023-09-30 | 1.18M shares 10-Q · filed 2024-11-13 | 1.15M shares derived: average of 2 quarters · filed 2024-11-13 | 1.12M shares 10-Q · filed 2024-11-13 | 7.45M shares derived: average of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | 1.13M shares 10-Q · filed 2024-08-13 | 1.10M shares 10-Q · filed 2024-08-13 | 9.54M shares derived: average of 3 quarters · filed 2024-08-13 | 7.41M shares derived: average of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | 26.46M shares 10-Q · filed 2023-05-12 | 13.75M shares derived: average of 2 quarters · filed 2024-04-01 | 9.51M shares derived: average of 3 quarters · filed 2024-04-01 | 7.37M shares derived: average of 4 quarters · filed 2024-04-01 | ||||
| 2022-12-31 | 1.03M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 1.03M shares derived: average of 2 quarters · filed 2024-04-01 | 1.01M shares derived: average of 3 quarters · filed 2024-04-01 | 1.00M shares 10-K · filed 2024-04-01 | 25.04M shares 10-K · filed 2023-03-30 | |||
| 2022-09-30 | 1.03M shares 10-Q · filed 2023-11-14 | 25.72M shares 10-Q · filed 2022-11-14 | 1.00M shares derived: average of 2 quarters · filed 2023-11-14 | 992.16K shares 10-Q · filed 2023-11-14 | 24.80M shares 10-Q · filed 2022-11-14 | 11.48M shares derived: average of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | 972.64K shares 10-Q/A · filed 2023-10-30 | 24.32M shares 10-Q · filed 2022-08-15 | 933.23K shares 10-Q/A · filed 2023-10-30 | 23.33M shares 10-Q · filed 2022-08-15 | 14.96M shares derived: average of 3 quarters · filed 2023-10-30 | 16.18M shares derived: average of 4 quarters · filed 2023-10-30 | ||
| 2022-03-31 | 23.15M shares 10-Q · filed 2023-05-12 | 21.96M shares derived: average of 2 quarters · filed 2023-05-12 | 21.25M shares derived: average of 3 quarters · filed 2023-05-12 | 20.34M shares derived: average of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | 20.76M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 20.30M shares derived: average of 2 quarters · filed 2023-03-30 | 19.40M shares derived: average of 3 quarters · filed 2023-03-30 | 18.59M shares 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | 19.85M shares 10-Q · filed 2022-11-14 | 18.72M shares derived: average of 2 quarters · filed 2022-11-14 | 17.86M shares 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | 17.59M shares 10-Q · filed 2022-08-15 | 16.85M shares 10-Q · filed 2022-08-15 | ||||||
| 2019-03-31 | 482.56K shares 10-Q · filed 2019-05-13 | |||||||
| 2018-12-31 | 243.18K shares 10-K · filed 2019-02-19 | |||||||
| 2018-03-31 | 174.28K shares 10-Q · filed 2019-05-13 | |||||||
| 2017-12-31 | 174.28K shares 10-K · filed 2019-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |